Comparison

Istradefylline (KW-6002)

Item no. V1483-50mg
Manufacturer InvivoChem LLC
CASRN 155270-99-8
Amount 50 mg
Quantity options 100 mg 10 mg 1 g 250 mg 25 mg 500 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V1483CAS #:155270-99-8Purity >=98%

Description: Istradefylline (formerly KW6002; KW 6002; KW-6002; Nourianz), a caffeine derivative, is an orally bioavailable and selective adenosine A2A receptor (A2AR) antagonist with anti-PD (Parkinson's disease) effects. It inhibits A2A receptor (A2AR) with a Ki of 2.2 nM. It has been approved to be used as an add-on treatment to levodopa/carbidopa for patients with Parkinson's disease experiencing 'off' episodes. Istradefylline reduces 'off' periods resulting from long-term treatment with the antiparkinson drug levodopa.

Description:

References: J Neurosci. 2001 May 15; 21(10):RC143; Psychopharmacology (Berl). 1999 Nov; 147(1):90-5.

References:

Related CAS: 160434-48-0 (4-Desmethyl Istradefylline)

Molecular Weight (MW)
384.43
Formula
C20H24N4O4
CAS No.
155270-99-8
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 6 mg/mL (15.6 mM)
Water: < 1 mg/mL
Ethanol: < 1 mg/mL
Solubility (In vivo)
30% Propylene glycol, 5% Tween 80, 65% D5W: 30 mg/mL
Synonyms
KW-6002; KW6002; KW 6002;

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close